Novan Therapeutics has been contracted by the Biomedical Advanced Research and Development Authority to produce a topical nitric oxide advanced healing (NOAH) treatment for burns.
The research authority, a sector of the Department of Health and Human Services, offered Novan a $7.8 million, two - year contract to develop the treatment. The grant will fund research into formulas, toxicology and proof - of - concept studies regarding serious thermal injuries.
Research has indicated that nitric oxide can expedite the relocation of skin cells, regulate inflamed cells, activate the growth of blood vessels and remodel wounds. There is a view to conduct clinical trials down the track.
Novan has already conducted NOAH technology research for its use in treating injuries sustained in combat, chronic wounds and infections that resist medication.
One possible use for the NOAH surface treatment is in the event of mass injuries. Presently these incidents may present more cases than can be handled by the existing burn - treatment facilities.